Published in J Virol on July 01, 2004
Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus. Microbiol Mol Biol Rev (2005) 3.18
Identification of nonessential regions of the nsp2 replicase protein of porcine reproductive and respiratory syndrome virus strain VR-2332 for replication in cell culture. J Virol (2007) 1.10
The M, E, and N structural proteins of the severe acute respiratory syndrome coronavirus are required for efficient assembly, trafficking, and release of virus-like particles. J Virol (2008) 1.03
Coronaviruses as vectors: stability of foreign gene expression. J Virol (2005) 0.99
Visualizing the replication cycle of bunyamwera orthobunyavirus expressing fluorescent protein-tagged Gc glycoprotein. J Virol (2010) 0.91
Coronavirus replicase-reporter fusions provide quantitative analysis of replication and replication complex formation. J Virol (2014) 0.85
Infectious Bronchitis Virus as a Vector for the Expression of Heterologous Genes. PLoS One (2013) 0.78
Negatively charged residues in the endodomain are critical for specific assembly of spike protein into murine coronavirus. Virology (2013) 0.76
Safe and Sensitive Antiviral Screening Platform Based on Recombinant Human Coronavirus OC43 Expressing the Luciferase Reporter Gene. Antimicrob Agents Chemother (2016) 0.75
Virus maturation by budding. Microbiol Mol Biol Rev (1998) 3.78
The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex. J Virol (2003) 3.71
Kinesin-dependent movement on microtubules precedes actin-based motility of vaccinia virus. Nat Cell Biol (2001) 3.67
Retargeting of coronavirus by substitution of the spike glycoprotein ectodomain: crossing the host cell species barrier. J Virol (2000) 3.46
Nucleocapsid-independent assembly of coronavirus-like particles by co-expression of viral envelope protein genes. EMBO J (1996) 3.33
Characterization of the budding compartment of mouse hepatitis virus: evidence that transport from the RER to the Golgi complex requires only one vesicular transport step. J Cell Biol (1994) 2.92
The group-specific murine coronavirus genes are not essential, but their deletion, by reverse genetics, is attenuating in the natural host. Virology (2002) 2.72
Live-cell analysis of a green fluorescent protein-tagged herpes simplex virus infection. J Virol (1999) 2.64
Cytoplasmic expression system based on constitutive synthesis of bacteriophage T7 RNA polymerase in mammalian cells. Proc Natl Acad Sci U S A (1990) 2.53
Site of addition of N-acetyl-galactosamine to the E1 glycoprotein of mouse hepatitis virus-A59. J Cell Biol (1988) 2.49
Tunicamycin resistant glycosylation of coronavirus glycoprotein: demonstration of a novel type of viral glycoprotein. Virology (1981) 2.34
Coronavirus M proteins accumulate in the Golgi complex beyond the site of virion budding. J Virol (1994) 2.27
Viral protein synthesis in mouse hepatitis virus strain A59-infected cells: effect of tunicamycin. J Virol (1981) 2.27
Intracellular transport of recombinant coronavirus spike proteins: implications for virus assembly. J Virol (1990) 2.21
Identification and characterization of a coronavirus packaging signal. J Virol (1992) 2.01
Characterization of the coronavirus M protein and nucleocapsid interaction in infected cells. J Virol (2000) 1.89
Heterologous gene expression from transmissible gastroenteritis virus replicon particles. J Virol (2002) 1.85
Envelope glycoprotein interactions in coronavirus assembly. J Cell Biol (1995) 1.79
Analysis of a recombinant mouse hepatitis virus expressing a foreign gene reveals a novel aspect of coronavirus transcription. J Virol (1997) 1.77
Coronavirus particle assembly: primary structure requirements of the membrane protein. J Virol (1998) 1.74
The membrane M protein carboxy terminus binds to transmissible gastroenteritis coronavirus core and contributes to core stability. J Virol (2001) 1.71
Genetic evidence for a structural interaction between the carboxy termini of the membrane and nucleocapsid proteins of mouse hepatitis virus. J Virol (2002) 1.69
Vesicular stomatitis virus glycoprotein containing the entire green fluorescent protein on its cytoplasmic domain is incorporated efficiently into virus particles. Virology (2001) 1.68
Monoclonal antibodies to the matrix (E1) glycoprotein of mouse hepatitis virus protect mice from encephalitis. Virology (1989) 1.66
Assembly of coronavirus spike protein into trimers and its role in epitope expression. J Virol (1990) 1.60
Identification of a receptor-binding domain of the spike glycoprotein of human coronavirus HCoV-229E. J Virol (2003) 1.57
Cooperation of an RNA packaging signal and a viral envelope protein in coronavirus RNA packaging. J Virol (2001) 1.56
Enhanced green fluorescent protein expression may be used to monitor murine coronavirus spread in vitro and in the mouse central nervous system. J Neurovirol (2002) 1.45
Mapping of the coronavirus membrane protein domains involved in interaction with the spike protein. J Virol (1999) 1.37
Fluorescent tagging of herpes simplex virus tegument protein VP13/14 in virus infection. J Virol (2001) 1.35
Characterization of an essential RNA secondary structure in the 3' untranslated region of the murine coronavirus genome. J Virol (2000) 1.35
Enhancement of the vaccinia virus/phage T7 RNA polymerase expression system using encephalomyocarditis virus 5'-untranslated region sequences. Gene (1991) 1.34
Assembly of spikes into coronavirus particles is mediated by the carboxy-terminal domain of the spike protein. J Virol (2000) 1.34
Coronavirus derived expression systems. J Biotechnol (2001) 1.32
Engineering the transmissible gastroenteritis virus genome as an expression vector inducing lactogenic immunity. J Virol (2003) 1.25
Coronaviruses as vectors: position dependence of foreign gene expression. J Virol (2003) 1.25
Quaternary structure of coronavirus spikes in complex with carcinoembryonic antigen-related cell adhesion molecule cellular receptors. J Biol Chem (2002) 1.23
Disulfide bonds in folding and transport of mouse hepatitis coronavirus glycoproteins. J Virol (1993) 1.21
Nucleocapsid-independent specific viral RNA packaging via viral envelope protein and viral RNA signal. J Virol (2003) 1.19
Comparison of six different murine coronavirus JHM variants by monoclonal antibodies against the E2 glycoprotein. Virology (1989) 1.18
Signal recognition particle-dependent insertion of coronavirus E1, an intracellular membrane glycoprotein. J Biol Chem (1985) 1.17
The S2 subunit of the murine coronavirus spike protein is not involved in receptor binding. J Virol (1995) 1.17
The S2 subunit of the spike glycoprotein of bovine coronavirus mediates membrane fusion in insect cells. Virology (1991) 1.02
Incorporation of green fluorescent protein into the essential envelope glycoprotein B of herpes simplex virus type 1. J Virol Methods (2002) 1.00
Biosynthesis and function of the coronavirus spike protein. Adv Exp Med Biol (1990) 0.90
The viral spike protein is not involved in the polarized sorting of coronaviruses in epithelial cells. J Virol (1998) 0.81
Identification of a receptor for mouse hepatitis virus. Adv Exp Med Biol (1987) 0.77
Expression of transcriptional units using transmissible gastroenteritis coronavirus derived minigenomes and full-length cDNA clones. Adv Exp Med Biol (2001) 0.77
Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08
Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature (2013) 6.39
The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex. J Virol (2003) 3.71
Coronaviruses Hijack the LC3-I-positive EDEMosomes, ER-derived vesicles exporting short-lived ERAD regulators, for replication. Cell Host Microbe (2010) 2.75
The group-specific murine coronavirus genes are not essential, but their deletion, by reverse genetics, is attenuating in the natural host. Virology (2002) 2.72
SARS coronavirus, but not human coronavirus NL63, utilizes cathepsin L to infect ACE2-expressing cells. J Biol Chem (2005) 2.36
Single-cell analysis of population context advances RNAi screening at multiple levels. Mol Syst Biol (2012) 2.13
Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides. Proc Natl Acad Sci U S A (2004) 1.89
Dissection of the influenza A virus endocytic routes reveals macropinocytosis as an alternative entry pathway. PLoS Pathog (2011) 1.66
Impaired Antibody-mediated Protection and Defective IgA B-Cell Memory in Experimental Infection of Adults with Respiratory Syncytial Virus. Am J Respir Crit Care Med (2015) 1.65
Live, attenuated coronavirus vaccines through the directed deletion of group-specific genes provide protection against feline infectious peritonitis. J Virol (2004) 1.62
Cleavage inhibition of the murine coronavirus spike protein by a furin-like enzyme affects cell-cell but not virus-cell fusion. J Virol (2004) 1.58
Recombinant soluble, multimeric HA and NA exhibit distinctive types of protection against pandemic swine-origin 2009 A(H1N1) influenza virus infection in ferrets. J Virol (2010) 1.55
Switching species tropism: an effective way to manipulate the feline coronavirus genome. J Virol (2003) 1.54
Cathepsin L functionally cleaves the severe acute respiratory syndrome coronavirus class I fusion protein upstream of rather than adjacent to the fusion peptide. J Virol (2008) 1.47
Qualitative and quantitative ultrastructural analysis of the membrane rearrangements induced by coronavirus. Cell Microbiol (2010) 1.43
Mouse hepatitis coronavirus replication induces host translational shutoff and mRNA decay, with concomitant formation of stress granules and processing bodies. Cell Microbiol (2007) 1.38
Adenosine deaminase acts as a natural antagonist for dipeptidyl peptidase 4-mediated entry of the Middle East respiratory syndrome coronavirus. J Virol (2013) 1.37
Mouse hepatitis coronavirus RNA replication depends on GBF1-mediated ARF1 activation. PLoS Pathog (2008) 1.36
Feline infectious peritonitis: insights into feline coronavirus pathobiogenesis and epidemiology based on genetic analysis of the viral 3c gene. J Gen Virol (2009) 1.36
The influenza A virus hemagglutinin glycosylation state affects receptor-binding specificity. Virology (2010) 1.33
Only two residues are responsible for the dramatic difference in receptor binding between swine and new pandemic H1 hemagglutinin. J Biol Chem (2010) 1.32
A single immunization with soluble recombinant trimeric hemagglutinin protects chickens against highly pathogenic avian influenza virus H5N1. PLoS One (2010) 1.28
Molecular interactions in the assembly of coronaviruses. Adv Virus Res (2005) 1.27
Coxsackievirus mutants that can bypass host factor PI4KIIIβ and the need for high levels of PI4P lipids for replication. Cell Res (2012) 1.27
Coronaviruses as vectors: position dependence of foreign gene expression. J Virol (2003) 1.25
Topology and membrane anchoring of the coronavirus replication complex: not all hydrophobic domains of nsp3 and nsp6 are membrane spanning. J Virol (2008) 1.23
Murine coronavirus with an extended host range uses heparan sulfate as an entry receptor. J Virol (2005) 1.18
Virulence of Newcastle disease virus: what is known so far? Vet Res (2011) 1.18
Structural protein requirements in equine arteritis virus assembly. J Virol (2004) 1.16
Coronaviruses maintain viability despite dramatic rearrangements of the strictly conserved genome organization. J Virol (2002) 1.15
Infectious bursal disease virus capsid protein VP3 interacts both with VP1, the RNA-dependent RNA polymerase, and with viral double-stranded RNA. J Virol (2002) 1.13
Gain, preservation, and loss of a group 1a coronavirus accessory glycoprotein. J Virol (2008) 1.12
Spike protein fusion peptide and feline coronavirus virulence. Emerg Infect Dis (2012) 1.09
Inhibition of the ubiquitin-proteasome system affects influenza A virus infection at a postfusion step. J Virol (2010) 1.09
Hemagglutinin receptor specificity and structural analyses of respiratory droplet-transmissible H5N1 viruses. J Virol (2013) 1.08
The 29-nucleotide deletion present in human but not in animal severe acute respiratory syndrome coronaviruses disrupts the functional expression of open reading frame 8. J Virol (2007) 1.07
Dynamics of coronavirus replication-transcription complexes. J Virol (2009) 1.07
Retracted Role of the SEL1L:LC3-I complex as an ERAD tuning receptor in the mammalian ER. Mol Cell (2012) 1.06
Complete genome sequence and taxonomic position of anguillid herpesvirus 1. J Gen Virol (2009) 1.04
The ubiquitin-proteasome system plays an important role during various stages of the coronavirus infection cycle. J Virol (2010) 1.04
Role of endocytosis and low pH in murine hepatitis virus strain A59 cell entry. J Virol (2007) 1.04
Cryo-electron tomography of mouse hepatitis virus: Insights into the structure of the coronavirion. Proc Natl Acad Sci U S A (2009) 1.02
Central ions and lateral asparagine/glutamine zippers stabilize the post-fusion hairpin conformation of the SARS coronavirus spike glycoprotein. Virology (2005) 1.01
The glycosylation status of the murine hepatitis coronavirus M protein affects the interferogenic capacity of the virus in vitro and its ability to replicate in the liver but not the brain. Virology (2003) 1.00
Sequence analysis of feline coronaviruses and the circulating virulent/avirulent theory. Emerg Infect Dis (2011) 0.99
Coronaviruses as vectors: stability of foreign gene expression. J Virol (2005) 0.99
Influenza A virus entry into cells lacking sialylated N-glycans. Proc Natl Acad Sci U S A (2012) 0.98
Visualizing coronavirus RNA synthesis in time by using click chemistry. J Virol (2012) 0.98
Rapid Emergence of Highly Pathogenic Avian Influenza Subtypes from a Subtype H5N1 Hemagglutinin Variant. Emerg Infect Dis (2015) 0.98
A mRNA PCR for the diagnosis of feline infectious peritonitis. J Virol Methods (2004) 0.97
Vaccinia virus-induced microtubule-dependent cellular rearrangements. Traffic (2006) 0.97
Formation of disulfide-linked complexes between the three minor envelope glycoproteins (GP2b, GP3, and GP4) of equine arteritis virus. J Virol (2003) 0.97
A protective and safe intranasal RSV vaccine based on a recombinant prefusion-like form of the F protein bound to bacterium-like particles. PLoS One (2013) 0.96
Characterization of two new structural glycoproteins, GP(3) and GP(4), of equine arteritis virus. J Virol (2002) 0.95
Evolution of the hemagglutinin protein of the new pandemic H1N1 influenza virus: maintaining optimal receptor binding by compensatory substitutions. J Virol (2013) 0.94
Mobility and interactions of coronavirus nonstructural protein 4. J Virol (2011) 0.93
Glycan-dependent immunogenicity of recombinant soluble trimeric hemagglutinin. J Virol (2012) 0.93
An autophagy-independent role for LC3 in equine arteritis virus replication. Autophagy (2012) 0.92
CD200 receptor controls sex-specific TLR7 responses to viral infection. PLoS Pathog (2012) 0.92
The coronavirus nucleocapsid protein is dynamically associated with the replication-transcription complexes. J Virol (2010) 0.92
Spike protein assembly into the coronavirion: exploring the limits of its sequence requirements. Virology (2005) 0.92
Manipulation of the porcine epidemic diarrhea virus genome using targeted RNA recombination. PLoS One (2013) 0.91
Identification and localization of the structural proteins of anguillid herpesvirus 1. Vet Res (2011) 0.90
Quantitative proteomic identification of host factors involved in the Salmonella typhimurium infection cycle. Proteomics (2011) 0.90
Vaccinia-virus-induced cellular contractility facilitates the subcellular localization of the viral replication sites. Traffic (2006) 0.90
The proteasome inhibitor Velcade enhances rather than reduces disease in mouse hepatitis coronavirus-infected mice. J Virol (2010) 0.88
Cooperative involvement of the S1 and S2 subunits of the murine coronavirus spike protein in receptor binding and extended host range. J Virol (2006) 0.88
Anguillid herpesvirus 1 transcriptome. J Virol (2012) 0.88
Pathogenic characteristics of persistent feline enteric coronavirus infection in cats. Vet Res (2010) 0.87
Identification of host factors involved in coronavirus replication by quantitative proteomics analysis. Proteomics (2010) 0.87